polypeptide
mediators
cystic
fibrosis
pp
although
complex
models
involving
multiple
loci
may
plausible
high
frequency
cystic
fibrosis
caucasians
probably
best
explained
selective
advantage
heterozygote
carrier
short
analogy
cystic
fibrosis
hemoglobin
sickle
cell
anemia
may
greater
tay
sachs
disease
terms
molecular
mechanisms
protein
polypeptide
differences
reported
humoral
fluids
cystic
fibrosis
patients
heterozygotic
relatives
connected
selected
bioassay
systems
directions
relate
model
proposed
intermediate
stages
physiology
cystic
fibrosis
builds
large
body
elegant
experimental
work
basic
tenet
cells
cystic
fibrosis
heterozygotes
normal
individuals
stimulatory
loop
chronic
reserpine
treatment
exaggerates
normal
rat
loop
similar
one
exaggerated
genetic
differences
human
elevating
pathological
levels
otherwise
normal
process
